Download - CHOLECYSTITIS CASE STUDY Version 2.0.docx

Transcript
  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    1/57

    I I N T R O D U C T I O N

    Description of the Disease

    The gallbladder is a small pear-shaped organ which aids in the digestive

    process. Its function is to store and concentrate bile - a digestive liquid continually

    secreted by the liver. The bile in turn emulsies fats and neutralizes acids in partly

    digested food. Despite its importance in the digestion of fat, many people are

    unaware of their gallbladder. ortunately enough, the gallbladder is an organ that

    people can live without. !erhaps, this fact contributes to the la"ity of the ma#ority.

    The gallbladder tends to be ta$en for granted % ignored of the proper care and

    conditioning. &ifestyle together with heredity, se", race and age are #ust some

    factors that leave a room for gallbladder complications to occur.

    's dened, cholecystitis is the in(ammation of the gall bladder. It came from

    the gree$ word )cholecyst* which means )gallbladder* and the su+" )itis* which

    means in(ammation. The in(ammation occurs mainly because of an obstruction of

    the cystic duct by a stone. loc$age of the cystic ductwith gallstonescauses

    accumulation of bile in the gallbladderand increased pressure within the

    gallbladder. oncentrated bile, pressure, and sometimes bacterial infection irritate

    and damage the gallbladder wall, causing in(ammation and swelling of the

    gallbladder. In(ammation and swelling of the gallbladder can reduce normal blood

    (ow to areas of the gallbladder, which can lead to cell death due to insu+cient

    o"ygen. ot everyone who has gallstones will go on to develop cholecystitis. !eople

    with history of gallstones are at high ris$ for having cholecystitis, as well as those

    who are obese and those with sedentary lifestyle. The most common presenting

    symptom of cholecystitis is upper abdominal pain. /owever, this may appear

    asymptomatic, initially. !hysical e"aminations may reveal fever, tachycardia, and

    tenderness in the 012 or epigastric region, often with guarding behaviour.

    Recent Trends, Innovations, and/ or Renements in Treatment

    Robotic Scarless Gallbladder Sr!er" # ScienceDail" $Dec% &&, '(&') *+

    3assar 3oussef, 4.D., is the rst surgeon in altimore ity to perform gallbladder

    surgery using #ust one incision and the da 5inci 6urgical 6ystem. ecause the single

    7 8 ! a g e

    http://en.wikipedia.org/wiki/Cystic_ducthttp://en.wikipedia.org/wiki/Gallstoneshttp://en.wikipedia.org/wiki/Gallbladderhttp://en.wikipedia.org/wiki/Gallstoneshttp://en.wikipedia.org/wiki/Gallbladderhttp://en.wikipedia.org/wiki/Cystic_duct
  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    2/57

    incision of about an inch is made in the patient9s navel, he or she is left without a

    noticeable scar. 'dditional patient benets are less pain, less blood loss and a faster

    recovery compared even with minimally invasive gallbladder removal that requires

    multiple incisions. This is good news for the one million 'mericans who need theirgallbladders removed each year, most of whom are candidates for this single-site,

    robotic approach.

    4ore than any other hospital in 4aryland, 6inai /ospital has made technologic

    investments in its da 5inci 6urgical 6ystem: in addition to having da 5inci 6ingle-6ite

    instruments that enable 3oussef to perform gallbladder removal, the hospital has

    two da 5inci units, an e"tra console allowing two surgeons to operate in tandem on

    a patient, and other advanced instruments. 6inai9s sister hospital, orthwest, alsohas its own da 5inci 6urgical 6ystem. 3oussef has plans to train other surgeons on

    the da 5inci, including those in 6inai9s surgical residency program. 6inai /ospital is a

    part of &iferidge /ealth, one of the largest, most comprehensive providers of

    health services in northwest altimore. &iferidge /ealth also includes orthwest

    /ospital, &evindale /ebrew ;eriatric enter and /ospital, ourtland ;ardens

    ursing < 0ehabilitation enter, and related subsidiaries and a+liates.

    Statistics $ocal - International)

    'bout 7=->=? of 'mericans have gallstones, and as many as one third of

    these people develop cholecystitis. @n the other hand, Indian and 6candinavian

    people have the highest prevalence of cholecystitis, it aAected >=.B million people

    with a record of appro"imately C,=== deaths in >=7>. /ospitalizations total up to

    E,=== in the same year and over B==,=== have undergone cholecystectomies.

    In the !hilippines alone, B, =CE, =F= people are aAected by the disease last >=77.

    ;enerally, the incidence of cholecystitis increases with age and it is >-E times more

    frequent in females than in males.

    Ob.ectives of the Std"

    % General Ob.ective

    > 8 ! a g e

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    3/57

    'fter the entire hospital rotation at 0afael &azatin 4emorial 4edical /ospital, the

    student nurses will be able toG

    Hnow and understand the disease process and concept of holecystitis.

    0% Specic Ob.ectives

    'fter the entire hospital rotation at 0afael &azatin 4emorial 4edical /ospital, the

    student nurses will be able toG

    Co!nitive 0eview the !roper !hysical 'ssessment I!!'J and how to do them e+ciently:

    1nderstand the Disease !rocessG the causes, eAects,

    management, treatment, and possible preventions:

    Determine the !athophysiology of the condition with their rationale for

    occurrence of each manifestation:

    Determine why certain management and medications are given and provided

    for the condition:

    1nderstand how and why certain diagnostic tests are done for the condition,

    and

    0eview the concepts about the 'natomy and !hysiology with regards to thedisease condition.

    1s"chomotor

    !erform proper physical assessment I!!'J to the patient e+ciently:

    !erform thorough health history from patient and signicant others:

    !articipate in the course of care of patient:

    !rovide health teachings to the patient about certain interventions in the

    maintenance of healthcare.

    2ective

    E 8 ! a g e

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    4/57

    Kstablish rapport and therapeutic interaction with the patient and signicant

    others to obtain necessary information and positive compliance to care being

    provided:

    !rovide care and health teachings necessary for the betterment of the

    condition of the patient.

    6hare the learning acquired to co-student-nurses to increase awareness and

    help them if ever they will encounter patient with the same condition.

    I% N U R S I N G 3 I S T O R 4

    0io!raphic Data

    This is a case of a F years old ilipino named 4r. aguit who was born on the

    >Cth day of ebruary 7LC. /e is currently living at 'ngeles ity. The client is

    married and has si" children and one grandchild all of which lives under the same

    roof with him and his wife. The clientMs main language for communication is

    Hapampangan but he also $nows how to spea$ Tagalog and Knglish as well.

    's stated by the patient, he e"perienced dizziness and an intolerable sharp

    stabbing pain in his abdominal area on the day of his hospitalization which made

    him decide to go to the hospital. /e was brought by his wife and was admitted at

    @spital ing 'ngeles last ovember 7L,>=7E at CGFBpm with the diagnosis of

    )holecystitis: 'nemia to be considered* under the care of the admitting physician

    Dr. ala#adia.

    1ast 5edical 3istor"

    During the one on one interview of the student nurse with the client, the

    client stated that he has complete immunization as child and had e"perienced only

    F 8 ! a g e

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    5/57

    a couple of minor illnesses for the past years such as cough, common colds, and

    fever.

    The patient had no record of previous hospitalizations and that this was his

    rst time to be conned in a hospital. 'lthough on the year of >==N, he had

    e"perienced an accident wherein he fell down from the stairs in the ;rotto in

    amban, Tarlac which gave him a sprain in his left foot but the client said that it was

    not that serious and did not required hospitalization.

    ifest"le

    @ur client usually wa$es up at BG== in the morning so as to help his wife

    prepare his children to go to school, after which he gets ready to go to wor$ as well.

    /e wor$s N hours a day as a driver of dump truc$s under the management of the

    government. /e wal$s to and from his wor$ which basically becomes his daily form

    of e"ercise. The patient eats E times a day, brea$fast, lunch and dinner respectively,

    and he mentioned that he loves to eat food high in cholesterol such as ried !or$,

    and hicharon. /e said that he is not pic$y when it comes to food but he en#oys

    eating and get to eat a lot when heMs eating fatty foods because it gives the food

    more (avor and ma$es it savory.

    /e has no vices, although he used to smo$e and drin$, according to him he

    decided to stop smo$ing ve months ago and was able to continue that change until

    now. 's for his alcohol consumption, the client said that he only drin$s alcoholic

    beverages during special occasions but in light to moderate consumption only. @ne

    of his ways to manage stress is to play with his grandchild,who for the client, gives

    #oy to the whole family and brighten up everyoneMs day in the aguitMs residence.

    1resent 3istor" of Illness

    Chief Complaint6 Di77iness and bdominal 1ain on the RU8

    ' month prior to admission, 4r. aguit e"perienced right upper quadrant pain

    associated with a sense of bloatedness and dizziness. The pain was tolerable so he

    B 8 ! a g e

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    6/57

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    7/57

    7&, at the level of B== cc, H5@, infusing well at his left hand. !atient was on !@ and

    complains of pain, with a pain scale of CQ7=. !atient was in good grooming wearing

    white shirt and maong pants.

    5ital 6igns ta$en are as followsG

    S=in6

    6$in was warm to touch, sli!htl" dr", ro!h,and with good s$in turgor.

    either #aundice nor cyanosis observed. o bruises or discolorations

    observed. o edema noted.

    3ead6

    6$ull and face were symmetrical with an equal distribution of hair. /air was

    blac$ in color. There was no dandruA or infestation present. o lesions,

    lacerations, tenderness, masses and depressions noted.

    :"es6

    The client has straight normal eye condition: >ith sli!ht icteric sclera.

    !upil is brown in color and equal in size: reactive to light and accomodation.

    /ave thin eyebrows.

    :ars6

    6$in color is same as facial s$in, auricle aligned with outer canthus of eye,

    mobile, rm, and not tender: pinna recoils after it is folded: presence of

    cermen noted%

    NoseG

    C 8 ! a g e

    9INDINGS I51R:SSION

    0OOD 1R:SSUR: 7>=QN=

    mm/g

    ormal

    1US: RT: CL bpm ormal

    R:S1IRTOR4 RT: 7 cpm ormal

    T:51:RTUR: EC.7 R

    Qa"illa

    ormal

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    8/57

    ose is uniform in color and has sli!ht dischar!es: there are no masses or

    tenderness upon palpation.

    5oth and Throat6

    &ips are pale: tongue is at the center and has no discharge: @ral cavity has

    no sores and lesions.

    Nec=

    ec$ was symmetrical with no masses or swelling noted. o #ugular vein

    distention was noted. 0ange of motion was normal and moves easily without

    discomfort upon rotation, (e"ion, e"tension and hypere"tension.

    Thora? and n!s6

    0espiratory rate was 7 cycles per minute with regular breathing pattern.

    6ymmetrical chest e"pansion was observed during respiration. o use of

    accessory muscles during breathing observed. hest wall was intact: no

    tenderness and masses noted. 1niform temperature also noted. o

    adventitious breath sounds heard upon auscultation. o cough present. o

    dyspnea, hemoptysis, hiccups noted.

    bdomen6

    bdomen >as sli!ht" enlar!ed and !loblarwhen patient was in supine

    position. Tenderness noted on the ri!ht pper @adrant >hen

    palpated%

    GenitoA Urinar"6

    1nable to perform inspection in the genitourinary region. /owever, patient

    verbalized that he had not seen any discharges from her genitalia nor

    presence of papules or ulcerations. The patient voided with a yellow colored

    urine.

    0ac= - :?tremities6

    N 8 ! a g e

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    9/57

    6ymmetrical shoulder movement observed during respiration. 6pine was

    located at the midline with no discrepancies noted. 6houlders, arms, elbows

    and forearms were free from nodules and deformities. 1pper e"tremities were

    not edematous. 0adial and brachial pulses were present. /ip #oint and thighswere symmetrical with no deformities present. o edema noted at both legs.

    o in(ammation noted in the lower e"tremities

    L 8 ! a g e

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    10/57

    IB% D I G N O S T I C S N D 0 O R T O R 4 R : S U T S

    Dia!nostic/aborator"procedres

    Dateordered/

    Datereslt$s)

    in6

    Indication$s)

    or1rpose$s)

    Reslt

    Normalvale$nits

    sed inthe

    hospital)

    nal"sisand

    Interpretation of

    Reslts

    3emo!lobin

    D@G 77-7C-7ED0G 77-7C-

    7E

    D@G 77->=-7ED0G 77->=-

    7E

    To measureprotein usedby red blood

    cell todistributeo"ygen tothe othertissue andcell in thebody

    NC

    E

    7F=-7N=gmQ&

    There is lowhgb level.The patient is

    possible tohave anemia.This indicatesthat thepatient haspoor blood9sability tocarry o"ygenthroughouthis body.

    3ematocrit D@G 77-7C-7ED0G 77-7C-7E

    D@G 77->=-7ED0G 77->=-7E

    To measurethe amountof blood thatis occupiedby the redblood cell

    =.>

    =.7L

    =.F=-=.BF&Q&

    There is lowhct level.This meansthat there isinsu+cientblood volumecomposed of0s, which

    are theresponsiblefor carryingo"ygen in thebody.

    7= 8 ! a g e

    /K4'T@&@;3

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    11/57

    R0C cont D@G 77-7C-7ED0G 77-7C-7E

    D@G 77->=-7ED0G 77->=-7E

    To measurethe numberof red bloodcells pervolume of

    blood anddeterminefor presenceofpolycythemia,dehydration,and anemia.

    E.=E

    >.>7

    F.B-.E"7=7>Q&

    Decreasedlevel of 0may indicatepresence ofanemia.

    Decreasedlevel of 0may indicatepresence ofanemia.

    0C ContD@G 77-7C-7ED0G 77-7C-7E

    D@G 77->=-7ED0G 77->=-7E

    To determineinfectionQin(ammation< also todetermineand evaluatethe bodyMsphysiologiccapacity toresist andovercomeinfection.

    7B.=

    7>.

    B-7= "7=Q&

    The elevatedvalue of theOs isindicative ofa bacterialinfectionwhich maybe due to thein(amedgallbladder.

    NetrophilsD@G 77-7C-7ED0G 77-7C-7E

    To determinepossiblepresence ofinfectionsand tissuenecrosis

    =.N7

    =.C

    .F=-CF? eutrophillevel is abovenormalrange. Itcouldsuggest thatthere is apresence ofviralinfection,tissuenecrosis,

    77 8 ! a g e

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    12/57

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    13/57

    is in thenormal rangethis meansthat thereare lesschances of

    developinghemorrhage.

    0lood T"pe D@G 77->=-7ED0G 77->=-7E

    ' bloodtype is usedto classifybloodbasedon thepresence orabsence ofinheritedantigenic6ubstanceson thesurfaceof red bloodcells0sJ.

    Type )'*0/ DJG!ositive

    !atientMsblood type istype ', 0/positive.

    Nrsin! Responsibilities

    efore During 'fter

    Chec= for the specic

    test ordered b" thedoctor%:?plain the test and >h"is it needed%

    Knsure that the blood

    sample is not ta$en from avein in the hand or armwith an intravenous line./emodilution withintravenous or plasma willlower the hematocrit valuefalsely.

    Instruct the 6@ to apply

    pressure to the puncturesite until bleeding stops.'ssess for hematomaformation.Document the testperformed

    :?plain to the patientthat it is normal for thepatient to feel pain and

    some discomforts >hileperformin! theprocedre%

    :?plain to the client thatan amont of blood >illbe e?tracted from thebrachial arm%

    7E 8 ! a g e

    http://en.wikipedia.org/wiki/Bloodhttp://en.wikipedia.org/wiki/Heredityhttp://en.wikipedia.org/wiki/Antigenhttp://en.wikipedia.org/wiki/Antigenhttp://en.wikipedia.org/wiki/Red_blood_cellhttp://en.wikipedia.org/wiki/Red_blood_cellhttp://en.wikipedia.org/wiki/Bloodhttp://en.wikipedia.org/wiki/Heredityhttp://en.wikipedia.org/wiki/Antigenhttp://en.wikipedia.org/wiki/Antigenhttp://en.wikipedia.org/wiki/Red_blood_cellhttp://en.wikipedia.org/wiki/Red_blood_cell
  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    14/57

    Dia!nostic/aborator"

    procedres

    Date

    ordered/Date

    reslt$s)

    in6

    Indication$s

    )

    or

    1rpose$s)

    Reslt

    Normal

    vale

    $nits

    sed in

    the

    hospital)

    nal"sis andInterpretatio

    n of Reslts

    0lood Urea

    Nitro!en

    $0UN)

    D@G 77->=-

    7E

    D0G 77->=-

    7E

    To assess

    renal

    functions

    and the

    ability of

    $idneys toe"crete urea

    and protein.

    TraditionalG

    E=.=

    6.IG

    7=.C7

    TraditionalG

    L- >=mgQdl

    6.IG

    E.>-

    C.7mmolQ&

    'n increase in

    the level of

    1 indicates

    an impaired

    $idney

    function.

    SG1T

    $Serm

    Gltamic

    1"rvicATransaminas

    e)

    D@G 77->=-

    7E

    D0G 77->=-

    7E

    6;!T is a

    specic

    indicator of

    liverdysfunction.

    6.IG

    EC.=

    6.IG

    >7-C> ulQl

    The result is

    within normal

    range.

    0U D@G 77->=-

    7E

    D0G 77->=-

    7E

    Determines

    how much

    uric acid is

    present in

    your blood.The test can

    help

    determine

    how well

    your body

    produces

    TraditionalG

    7B.F

    6.IG

    L7.E

    TraditionalG

    E.B-

    N.BmgQdl

    6.IG

    >=N-B=umolQ&

    'n increase in

    the level of

    1 indicates

    a impaired

    $idneyfunction.

    7F 8 ! a g e

    &@@D /K4I6T03

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    15/57

    and removes

    uric acid.

    30s!

    $3epatitis 0

    srfaceanti!en

    screenin!)

    D@G 77->=-

    7E

    D0G 77->=-7E

    Diagnosis of

    acute,recent, or

    chronic

    hepatitis

    infection

    Determinatio

    n of chronic

    hepatitis

    infection

    status

    on

    0eactive

    on

    0eactive

    NTIA 3CB

    Screenin!

    D@G 77->=-

    7E

    D0G 77->=-

    7E

    Diganosis of

    /epatitis

    5irus.

    on

    0eactive

    on

    0eactive

    Nrsin! Responsibilities

    efore During 'fter

    Chec= for the specictest ordered b" thedoctor%

    Oipe with cotton balls andalcohol the site whereinsertion is done

    Tell the 6@ when the needlewill be inserted for them toget prepared

    Instruct the 6@ to applypressure to the puncturesite until bleeding stops.

    :?plain the test and >h"is it needed%

    'ssess the site forhematoma formation.

    7B 8 ! a g e

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    16/57

    Inform that there are nofood or id restrictions

    Inform that the testre@ires blood sample,

    tell >ho >ill do the testand >hen

    Tell that there >ill bediscomfort from theneedle that >ill beinserted and pressrefrom the torni@et%

    If the patient is bein!treated for infection,advise that the test >illbe repeated severaltimes to maintain thepro!ress%

    Document the testperformed.

    :?plain to the client thatan amont of blood >illbe e?tracted from thebrachial arm%

    !urpose 0esult Interpretation

    7 8 ! a g e

    1&T0'6@1D 0K!@0T

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    17/57

    3O:

    0DO5INUTRSOUND

    4edical test that uses high-

    frequency sound waves to

    capture live images from

    the inside of your body,

    which help the military

    detect planes and ships

    also allows doctor to see

    problems with organs,

    vessels, and tissues without

    needing to ma$e an

    incision.

    Ri!ht iver obeG 7F.= " 77.N " 7=.B cmeft iver obe G E.LN " F.LB " E.C7 cmGallbladder G N.7= " >.B cmSpleen G 77.> " E.N cm1ancreas G =.LB " 7.7> " =.Lcm / "

    " TJRi!ht Eidne" G L.FC " F.FF cmCortical Thic=ness67.L cmeft Eidne" G L.> " B.>7 cmCortical Thic=nessG 7.LL cm1rostate G >.N7 " >.N " >.CLcm 77.CgramsJ

    The liver and spleenare slightly enlarged.It has smooth contour and homogenousparenchymal echo pattern.

    The !allbladderis slightly dilated. The wallsare thic$ened o.BN cmJ There are severalhigh lever echoes noted within, measuringan average of =.FLcm. The c"stic dct is7=mm with an 77mm shadowingcalcication at the pro"imal segment.

    1ancreas is normal in size. !arenchymalechopattern is uniform. 1ancreatic dctsare not dilated.

    Urinar" bladder is adequately distended.o intravesical echoes seen. The prostate!land is not enlarged. !arenchymalechopattern is homogenous.

    @bstructed biliarydisease with the

    presence of stonesin the cystic duct.Intrahepatic ductsare dilated and gallbladder isdistended. onsiderhocystitis.

    Nrsin! Responsibilities $hole abdominal Ultrasond)6

    1reprocedral Care6

    7. hec$ for the specic test ordered by the doctor.>. hec$ for materials needed.E. 6ecure a laboratory request.

    F. K"plain the procedure to the 6@.

    B. Inform that there the patient is not allowed to eat and can only drin$

    with small amount of water in ta$ing medicines.

    . Inform the patient about the procedure. Tell himQher that there will be

    no discomfort while doing the procedure.

    7C 8 ! a g e

    http://www.healthline.com/human-body-maps/chest-blood-vesselshttp://www.healthline.com/human-body-maps/chest-blood-vessels
  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    18/57

    Drin! the test patient care.

    7. 'ssisting to adhere to standard precautions.

    >. !rovide emotional support.

    E. 'ssist the patient and the physician during the procedure

    1ostprocedral Care6

    7. @btain results and secure it to the patientMs chart.

    >. 0efer the results to the physician.

    E. Document the test performed.

    Dia!nostic/aborator"procedres

    Dateordered/

    Datereslt$s)

    in6

    Indication$s)or

    1rpose$s)

    Reslt

    Normalvale$nits

    sed inthe

    hospital)

    nal"sis andInterpretation

    of Reslts

    URIN4SIS D@G 77-7C-

    7ED0G 77-7C-

    7E

    The

    diagnostictest is

    performed

    for the

    general

    evaluation

    of the

    patientMs

    health. It

    helps in

    identifyingmetabolic

    and

    systemic

    diseases or

    olorG 3ellow 6traw to

    dar$yellow

    0esult indicates

    normal nding.

    Transparency

    6lightly

    turbid

    lear

    0esult may

    indicate the

    presence of

    particulate

    matters such as

    bile, bacteria, pus

    and hemolysis.

    p/G .B

    'cidicJ

    p/ .B %

    N.=

    0esult indicates

    normal nding.

    reshly voided

    urine is normally

    somewhat acidic

    7N 8 ! a g e

    10I'&36I6

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    19/57

    disorders

    that aAect

    the $idney

    and

    urinary

    tract.

    1rinalysis

    is ordered

    to identify

    any

    deviation

    that may

    indicate

    the

    diagnosisof the

    patient.

    6p. ;r.G 7.=>= 7.==B %

    7.=EB

    0esult is within

    normal range.

    'lbuminG SE

    Trace

    egative

    %J

    unctionalalbuminuria maybe present duringacute illness butis #ust temporary.This may alsoindicate 0enaldisease

    6ugarGegative %J

    egative%J

    0esult indicatesnormal nding.

    5ICROSCO1IC 9INDINGS

    !us cellsG

    =.>Qhpf

    Kpithelial

    ellsGew

    one 0esult may

    indicate urinary

    tract infection

    alterations in$idney function.

    7L 8 ! a g e

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    20/57

    NURSING R:S1ONSI0IITI:S6

    1re procedral care6

    7. hec$ the doctorMs order.

    >. K"plain to the patient and 6@ the procedure and purpose of

    urinalysis.

    E. !rovide clean specimen cup.

    F. K"plain to the patient to obtain midstream urine.

    B. 'dvise the patient to wash urinary meatus prior to collecting the

    specimen to avoid contamination.

    . Inform the patient that there is no (uid and food restriction

    needed.

    >= 8 ! a g e

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    21/57

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    22/57

    The biliary system consists of the organs and ducts bile ducts, gallbladder,

    and associated structuresJ that are involved in the production and transportation of

    bile. The transportation of bile follows this sequenceG

    Ohen the liver cells secrete bile, it is collected by a system of ducts

    that (ow from the liver through the right and left hepatic ducts.

    These ducts ultimately drain into the common hepatic duct.

    The common hepatic duct then #oins with the cystic duct from the

    gallbladder to form the common bile duct, which runs from the liver to

    the duodenum the rst section of the small intestineJ.

    /owever, not all bile runs directly into the duodenum. 'bout B=

    percent of the bile produced by the liver is rst stored in the

    gallbladder, a pear-shaped organ located directly below the liver.

    Then, when food is eaten, the gallbladder contracts and releases

    stored bile into the duodenum to help brea$ down the fats.

    9nctions of the 0iliar" S"stem

    The biliary system9s main function includes the followingG

    >> 8 ! a g e

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    23/57

    a. to drain waste products from the liver into the duodenum

    b. to help in digestion with the controlled release of bile

    0ile is the greenish-yellow (uid consisting of waste products, cholesterol, and bile

    saltsJ, required for the digestion of food. It is secreted by the liver cells to perform

    two primary functions, including the followingG

    a. to carry away waste products, and

    b. to brea$ down fats during digestion

    ile salt is the actual component which helps brea$ down and absorb fats. Oithout

    adequate bile, our body cannot metabolize fats which can result in a deciency ofthe fat-soluble vitamins ', D, K and HJ. Oe may also have problems digesting the

    essential fatty acids. 'mongst other symptoms we could have trouble utilizing

    calcium, have dry s$in, peeling on the soles of your feet, etc. @ne way we can tell

    we have trouble digesting fats is if we have e"cessive burping that starts shortly

    after eating a meal that has fat in it. Oe might feel nauseous or e"perience gas and

    bloating. ile, which is e"creted from the body in the form of feces, is what gives

    feces its dar$ brown color.

    G0DD:R

    The gallbladder is a small pouch that sits #ust under the liver. The gallbladder or

    cholecyst or gall bladderJ is a small non-vital organ that aids in the digestive

    process and stores bile produced in the liver. It stores bile produced by the liver.

    'fter meals, the gallbladder is empty and (at, li$e a de(ated balloon. efore a meal,

    the gallbladder may be full of bile and about the size of a small pear.

    >E 8 ! a g e

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    24/57

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    25/57

    C4STIC DUCT

    The cystic duct is the short duct that #oins the

    gall bladder to the common bile duct. It usually

    lies ne"t to the cystic artery. It is of variable

    length. It contains a 9spiral valve9, which does

    not provide much resistance to the (ow of bile.

    ile can (ow in both directions between the

    gallbladder and the common hepatic duct andthe commonJ bile duct. In this way, bile is

    stored in the gallbladder in between meal times

    and released after a fatty meal.

    CO55ON 3:1TIC DUCT

    The common hepatic duct is the duct formed by the convergence of the righthepatic duct which drains bile from the right functional lobe of the liverJ and the

    left hepatic duct which drains bile from the left functional lobe of the liverJ. The

    common hepatic duct then #oins the cystic duct coming from the gallbladder to form

    the common bile duct.

    PATHOPHYSIOLOGY

    (Book Based)

    >B 8 ! a g e

    Precipitating Factors:

    Diet

    Medications and Oral Contraceptives

    Obesity

    Rapid Weight Loss

    Spinal Cord Injury

    Primary iliary Cirrhosis

    Diabetes Mellitus

    !emolytic Syndromes

    Ileal Disease" Resection and ypass

    iliary In#ection

    Predisposing Factors:

    $ender

    %ge

    Race

    !eredity

    Pregnancy

    acterial

    hydrolysis

    of lecithin

    1ncon#ug

    ilirubin t

    to form

    insolubprecipita

    ormatio

    alciuilirubin

    &iver e"

    som

    uncon#u

    bilirubinbile

    alcium e

    bile pass

    along w

    otheelectroly

    Increase in

    uncon#ugate

    d bilirubin 0elease offatty acids

    The bacteria

    hydrolyze

    con#ugated

    bilirubin

    Invasion

    ofbacteria

    &iver

    e"crete

    con#ugated

    bilirubin intobile

    &iver e"crete

    relatively high

    proportion of

    cholesterol inthe bile

    &iver cells

    also

    secrete

    bile salts0esidual ormation ofmi"ed micelles

    6ome of the

    unilamellarvesicles

    &iver cells secrete

    cholesterol into bile

    along with

    phospholipid in the

    form of unilamellarvesicles

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    26/57

    > 8 ! a g e

    ucleation of

    cholesterol

    cr stals

    ormation of

    rystals

    ile is

    supersaturated

    with cholesterol

    The cholesterol

    carrying capacity

    of the micelles

    and residual

    vesicles is

    Cholesterol

    Gallstones

    5i?ed

    Stones

    leu$ocyte

    s

    hydrolyze

    bilirubin

    con#ugate

    s and

    'ttractionof

    &eu$ocyte

    acteriarelease

    lytic

    enzyme

    0ro>n

    1i!ment

    Gallstones

    ormation of

    alcium

    ilirubinate

    A fatty acids fo

    comple" wi

    0lac

    1i!me

    Gallsto

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    27/57

    >C 8 ! a g e

    6Q6

    Indigestion,

    5it 'DKH

    deciency,ibrosis

    &iver irrhosis

    Irritation of th

    gallbladder w

    /ydrolization of lecithin

    intolysolecithinDamages muco

    cells due to dete

    action of bile sa

    0elease of

    phospholipase from the

    epithelium of the

    Disruption of mu

    coat of the gallbla

    epithelium

    /epatomegaly

    6Q6 #aundice,

    ecteric sclera,

    pruritus, dar$

    urine

    U levels of

    bilirubinQbile

    pigments in the

    circulation

    'bsence of ile

    in the duodenum

    !rolong

    holestasis

    holestasis

    @bstruction of the

    common bile duct by

    gallstones

    holedocholelithiasi

    s

    @bstruction o

    cystic duct

    gallstone

    ;allstone tries to

    go out of the

    C3O:IT3ISIS

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    28/57

    >N 8 ! a g e

    6Q6 iliary olic,

    Tenderness,

    4urphyMs sign,

    nausea and

    vomiting, fever,

    elevated wbc

    K0esistance to

    portal blood (ow

    ibrous nodules distorts

    the architecture of the

    CUT:

    C3O:C4ST

    0elease of prostagla

    within the gallblad

    F

    !ortal /ypertension

    Increase

    pressure in

    Kdema, hemorrhag

    suppuration of t

    gallbladder wa

    acteria invade

    in#ured gallblad

    through the blo

    lymphatic or b

    ducts form ad#a

    organs

    Kmpyema of

    gallbladder

    K"tern

    surface o

    gallbladd

    scarred

    layered

    brino

    e"udates

    distend

    I @T T0K'T

    ;@@D !0@;@6I6

    I T0K'TKDG

    @pen holecystectomy

    &aparoscopic

    holecystectomy

    &itotripsy

    1rsodeo"ycholicacid

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    29/57

    >L 8 ! a g e

    Gangrenos

    !"o#ec$stitis

    ecrosis

    1lcerations of the

    mucosa

    Ischemia

    ompromised blood

    (ow to the mucosa

    and lymphatic stasis

    IncreasedIntraluminal pressure

    ompression of

    blood vessels

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    30/57

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    31/57

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    32/57

    E> 8 ! a g e

    F

    loc$age or increase

    pressure in the portal veincauses blood to bac$(ow to

    the diAerent vessels located

    near the esophagus and ;ITluid shifting fro

    the portal vein t

    peritoneal cavit

    Increase pressur

    peritoneal capill

    6pleen enlarges to

    compensate

    decreased liver

    6hunting of blood

    into the splenic vein

    &iver is unable to

    convert the

    protein byproduct

    ammonia into

    &iver failure

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    33/57

    EE 8 ! a g e

    /ypovolemi

    /ypovolemic

    Death

    6

    D

    6eptic

    6Q6

    Thrombocyto

    penia,

    anemia,

    leu$openia

    Death

    Increases in blood

    waste product since

    spleen is not able

    to properly destroy

    0Ms

    Increase in sizedecreases the

    spleenMs ability to

    function properly or

    loss of function

    6Q6

    'steri"i

    6Q6 eve

    diarrhea

    abdomin

    6pontaneo

    acterial !erit

    Invasion ofbacteria fro

    the blood, o

    lymph or

    through the

    's

    0upture

    ;astroesophageal

    5arices

    6plenomegal

    6Q6 'nore"ia, ausea,&iver tenderness,aundice

    /K!'TI

    Development of a

    large pale nucleus,

    a prominent

    nucleolus, and

    margination of

    'strocytes become

    swollen

    'strocytes may

    undergo 'lzheimer

    type II astrocytosis

    4orphologic

    changes in

    'mmonia enters

    general circulation

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    34/57

    S"nthesis of the Disease6holecystitis is dened as in(ammation of the gallbladder that occurs most

    commonly because of an obstruction of the cystic duct from cholelithiasis. It is

    caused by an obstruction of the cystic duct, leading to distention of the gallbladder.

    's the gallbladder becomes distended, blood (ow and lymphatic drainage are

    compromised, leading to mucosal ischemia and necrosis.

    1redisposin! 9actors6

    Gender6 Oomen have twice the ris$ as men of developing cholesterol gallstones

    because estrogen increases biliary cholesterol secretion. efore puberty this ris$ is

    negligible, and beyond menopause the increased ris$ disappears.

    EF 8 ! a g e

    erebral edema

    Increased

    intracranial

    rain /ernation

    /epatic oma

    D:T3

    http://emedicine.medscape.com/article/171886-overviewhttp://emedicine.medscape.com/article/171886-overview
  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    35/57

    !e6The incidence increases with age. &ess than B-? of the population under age

    F= have stones, in contrast to >B-E=? of those over N=.

    Race6 !revalence highest in orth 'merican Indians, hilean Indians, and hilean

    /ispanics, greater in orthern Kurope and orth 'merica than in 'sia, lowest in

    Vapan: familial disposition: hereditary aspects

    3eredit"6 amily history alone imparts increased ris$, as do a variety of inborn

    errors of metabolism that lead to impaired bile salt synthesis and secretion or

    generate increased serum and biliary levels of cholesterol, such as defects in

    lipoprotein receptors hyperlipidemia syndromesJ, which engender mar$ed

    increases in cholesterol biosynthesis.

    1re!nanc"6 !regnancy is an independent ris$ factor for cholesterol gallstones. Theris$ increases with increasing parity, especially with more than two children. During

    pregnancy, elevated estrogen and progesterone levels increase biliary cholesterol

    secretion. Klevated progesterone also inhibits gallbladder contractility. F=? of

    women develop biliary sludge in their gallbladder and 7>? of women form their rst

    stones during pregnancy. The incidence of gallstones is higher in women with

    multiple pregnancies.

    1recipitatin! 9actors6

    Diet $3i!h 9at, 3i!h Sodim)6Increased inta$e of calories, rened carbohydrate,

    cholesterol, and saturated fats has all been postulated to cause cholesterol

    gallstones. !atients with cholesterol gallstones secrete a greater fraction of dietary

    cholesterol into bile than do normal sub#ects.

    5edications and Oral ContraceptivesG /ypolipidemic agents clobrate,

    gembrozilJ that lower serum cholesterol by increasing biliary cholesterol secretion

    increase the ris$ of cholesterol gallstones by twofold to threefold. ompetitive

    inhibitors of E-hydro"y-E-methylglutaryl coenzyme ' /4;o'J reductase

    lovastatin, simvastatin, pravastatinJ decrease biliary cholesterol saturation.

    Kstrogen therapy is associated with an increased ris$ of developing cholesterol

    EB 8 ! a g e

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    36/57

    gallstones. @ral contraceptive steroids increase biliary cholesterol secretion and

    saturation but do not aAect gallbladder motility.

    Obesit"G @besity is strongly associated with increased gallstone prevalence. The

    ris$ is proportional to the increase in total body fat. @bese people synthesize more

    cholesterol in both hepatic and nonhepatic tissues, transport it to the liver, and

    secrete more of it into the bile, leading to bile that is often greatly supersaturated

    with cholesterol.

    Rapid ei!ht oss6@bese patients undergoing rapid weight loss 7->? of body

    weight or appro"imately 7-> $gQwee$J, either by very low caloric dieting or gastric

    stapling, have a >B-F=? chance of developing gallstones within F months. During

    rapid weight loss, biliary cholesterol saturation increases acutely as cholesterol is

    mobilized from adipose tissue and s$in and secreted into bile.

    Spinal Cord In.r"6!atients with spinal cord in#ury have 7=? incidence of forming

    gallstones within the rst year after in#ury. This high ris$, which is >= times normal,

    is believed to be secondary to abnormal gallbladder motility and probably biliary

    hypersecretion of cholesterol from the progressive reduction in body mass.

    1rimar" 0iliar" Cirrhosis6!atients with primary biliary cirrhosis have an increased

    prevalence of gallstones. 6tone analysis has not been performed, but the elevated

    cholesterol saturation of bile in these patients suggest that they form cholesterol

    stones.

    Diabetes 5ellits6Despite obesity and increased total body cholesterol synthesis

    and decreased gallbladder motility seen in patients with diabetes, diabetes mellitus

    itself does not appear to be an independent ris$ factor for cholesterol gallstone

    disease.

    3emol"tic S"ndromes6 Inherited hemolytic anemia, sic$le cell disease,

    sphericytosis, thalassemia, chronic hemolysis associated with articial heart vavles,

    and malaria dramatically increase the ris$ of pigment stone formation because of

    increased biliary secretion of total bilirubin con#ugates, especially bilirubin

    monoglucoronide, at the e"pense of the bilirubin diglucuronide, the predominant

    con#ugate in healthy individuals.

    E 8 ! a g e

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    37/57

    Ileal Disease, Resection and 0"pass6 !atients with ileal dysfunction have a

    stri$ingly increased ris$ for developing gallstones. ;allstones develop in E=-B=? of

    patients with ileal hronMs disease: the ris$ correlates positively with the e"tent and

    duration of ileal dysfunction, 'lthough ilieal disease or resection leads to cholesterol

    supersaturation and cholesterol stone formation in some patients , careful studies

    now show that most patients with ilieal dysfuncyion form blac$ pigment, not

    cholesterol stones.

    0iliar" Infection6 rown pigment stones are frequently found in the intrahepatic

    bile ducts and are always associated with infection by colonic organisms usually

    K.coli, or parasitic infestation 'scaris lumbricoides, or other helminthesJ.

    Intraductal stones developing after cholecystectomy are invariable associated with

    bile stasis, biliary tree infection, andQor retained suture material.

    Si!ns and S"mptoms6

    0iliar" Colic/ 5oderate to Severe 1ain6The most common symptom is in pain

    the right upper part of the abdomen or epigastrium. This can cause an attac$ of

    abdominal pain, called biliary colic, whichG develops quic$ly, is severe, lasts about

    one to three hours before fading gradually, isn9t helped by over-the-counter and

    isn9t helped by passing wind. The pain may radiate to the bac$, right scapula or

    shoulder. The pain often begins suddenly following a meal. The pain of biliary colic is

    caused by the functional spasm of the cystic duct when obstructed by stones,

    whereas pain in acute cholecystitis is caused by in(ammation of the gallbladder

    wall.

    Tenderness6 !alpation of the abdomen frequently elicits localized tenderness in the

    right upper quadrant which is associated with guarding and rebound tenderness.

    5rph"s Si!n6The patient with acute in(ammation of the gallbladder might have

    a positive 4urphyMs sign, which is inspiratory arrest during deep palpation in the

    right upper quadrant.

    EC 8 ! a g e

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    38/57

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    39/57

    EL 8 ! a g e

    Irritation of the Spersaton of 0i

    Srface chan!es9ormation

    small

    Increased mcos

    Cr"stal

    enlar!es

    Increased

    mcos

    Obstrction of

    2ectation and Obstrction

    of the

    Common 0ile Dct

    0acterial

    invasion

    iver

    Impairme

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    40/57

    S"nthesis of the Disease6;allstones can form anywhere in the biliary tree, however the point of origin is

    within the gallbladder. ;allstones develop when an individual eats too much fatty

    and salty foods that causes an increase in bile cholesterol, therefore, causing an

    irritation of the gall bladder. The surface changes within the gallbladder and mucous

    secretion increases as a form of a compensatory mechanism. The bile, however,

    becomes more viscous ma$ing hard for the gallbladder to contract and secrete bile.

    6mall crystals form and enlarges into visible stones. These stones or what we

    commonly call )gallstones* tries to get out of the gallbladder. The stone then passes

    on the cystic and common bile ducts which later on causes an obstruction. 6ince

    there is an obstruction, the gallbladder can no longer secrete bile causing

    indigestion, vitamin ',D,K and H deciency and gray stool. There will also be an

    increase in the levels of bilirubinQbile pigments in the circulation, thus, ma$ing the

    F= 8 ! a g e

    Inammation

    HUNDIC: N:5RU8 pain

    $) 5rph"s

    Increase

    d 0C

    C3O:C4STITIS

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    41/57

    sclera and the s$in yellowish in color. 'lso, this obstruction causes an irritation in

    the gallbladder wall, and an in(ammatory response happens through the release of

    prostaglandins. Ohen prostaglandins are released, symptoms such as tenderness,

    012 pain, murphyMs sign, nausea, vomiting, anore"ia and an elevated wbc

    happensQmanifests. Thus, cholecystitis happens.

    1redisposin! 9actors6

    !e6The incidence increases with age. &ess than B-? of the population under age

    F= have stones, in contrast to >B-E=? of those over N=.

    1recipitatin! 9actors6

    Diet $3i!h 9at, 3i!h Sodim)6Increased inta$e of calories, rened carbohydrate,

    cholesterol, and saturated fats has all been postulated to cause cholesterol

    gallstones. !atients with cholesterol gallstones secrete a greater fraction of dietary

    cholesterol into bile than do normal sub#ects.

    Si!ns and S"mptoms6

    Tenderness6 !alpation of the abdomen frequently elicits localized tenderness in the

    right upper quadrant which is associated with guarding and rebound tenderness.

    5rph"s Si!n6The patient with acute in(ammation of the gallbladder might have

    a positive 4urphyMs sign, which is inspiratory arrest during deep palpation in the

    right upper quadrant.

    Nasea and Bomitin!6These signs and symptoms may accompany a gallbladder

    attac$. !ain is usually accompanied by nausea and vomiting.

    oss of appetite and nore?ia6The pain often begins suddenly following a large

    or rich meal. !eople tend not to eat, especially fatty or oily foods, in order not to

    e"perience that pain. at absorption is also impaired for the lac$ of bile salts, 's a

    result, rapid loss of weight and anore"ia can occur.

    F7 8 ! a g e

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    42/57

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    43/57

    RR0(? cpm

    Problem : Activit! Intolerance

    Cues Nursing Diagnosis Scientific Explanation Planning Intervention

    Subjective Cues:

    %"Maniat mi$ala

    ku hospital

    mangalamut naku!"

    ,s verali#e$ y the

    patient!

    Objective Cues:

    %Difficulty in

    changing e$

    position

    %@enerali#e$+eakness

    %Aimite$ range of

    motion

    %Nee$s assistance

    +hen $oing ,DA

    :e!g! going to toilet8

    changing clothes!;

    %.ital Signs

    /P0 (1)'2)mm3g

    4emp0 5&!(C

    PR0 &6 pm

    RR0(? cpm

    %,ctivity Intolerance

    relate$ to general

    +eakness!

    %,ctivity intolerance is

    affecte$ y any $isor$er

    that impairs the aility

    of the nervous system8

    musculoskeletal

    system8 car$iovascular

    system8 respiratory

    system an$ vestiular

    apparatus!

    ,fter < hours of

    nursing

    interventions the

    client +ill e ale

    to0

    %I$entify

    alternative +ays

    to maintain

    $esire$ activity

    level!

    %,sk the client aout the

    usual level of energy!

    %I$entify factors8 such as

    age an$ painful

    con$itions!

    %Instruct the client in

    unfamiliar activities an$

    in alternate +ays of

    $oing familiar activities!

    %Discuss +ith client'S9

    the relationship of illness

    ' $eilitating con$ition to

    inaility to perform

    $esire$ activities!

    %I$entify an$ $iscuss

    symptoms for +hich

    client nee$ to see

    me$ical assistance or

    evaluation!

    FE 8 ! a g e

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    44/57

    Problem ": Ris# $or %e$icient &lui% 'olume

    Cues Nursing Diagnosis Scientific Explanation Planning Intervention

    Subjective Cues:

    %"Mana+a ku pong

    $anum" ,s

    verali#e$ y the

    patient!

    Objective Cues:

    %Dry skin

    %@eneral +eakness

    %Dry lips

    %.ital Signs

    /P0 (1)'2)mm3g

    4emp0 5&!(C

    PR0 &6 pm

    RR0(? cpm

    Risk for $eficient

    flui$ volume relate$

    to ina$e>uate flui$

    intake

    Deficient *lui$ .olume

    is $ecrease$

    intravascular8

    interstitial8 an$'or

    intracellular flui$! 4his

    refers to $ehy$ration8

    +ater loss alone

    +ithout change in

    so$ium!

    ,fter < hours of

    nursing

    intervention the

    client +ill e ale

    to0

    %Demonstrate

    ehaviors or

    lifestyle changes

    to prevent

    $evelopment of

    flui$ volume

    $eficit!

    %Evaluate nutritional

    status8 noting current

    intake8 type of $iet!

    %Monitor I'9 alance8

    eing a+are of altere$

    intake or output!

    %Estalish in$ivi$ual

    flui$ nee$s ' replacement

    sche$ule!

    %Provi$e supplemental

    flui$s8 as in$icate$!

    Problem (: )no*le%+e ,e$icit

    Cues Nursing Diagnosis Scientific Explanation Planning Intervention

    Subjective Cues:

    %"Nanu +ari

    talagang kun$isyun

    ku " ,s verali#e$

    y the patient!

    Objective Cues:

    Deficient kno+le$ge

    relate$ to con$ition8

    prognosis8 treatment8

    self-care an$

    $ischarge nee$s!

    4here is this presence

    of kno+le$ge $eficit

    $ue to some unfamiliar

    information that causes

    some confusion to the

    client that nee$s to e

    $iscusse$!

    ,fter < hours of

    nursing

    intervention the

    client +ill e ale

    to0

    %.erali#e

    %Provi$e explanations

    of'reasons for test

    proce$ures an$

    preparation nee$e$!

    %Revie+ $isease

    process'prognosis!

    FF 8 ! a g e

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    45/57

    %*re>uently asking

    >uestion aout his

    con$ition8 treatment

    an$ $iet!

    %orrie$ ga#e

    un$erstan$ing of

    $isease process8

    prognosis an$

    potential

    complications!

    Discuss hospitali#ation

    an$ prospective

    treatment as in$icate$!

    Encourage >uestions8

    expression of concern!

    %Revie+ $rug regimen8

    possile si$e effects!

    %Instruct patient to avoi$

    foo$'flui$s high in fats

    or gastric irritants!

    %Suggest patient to limit

    gum che+ing8 sucking

    on stra+' har$ can$y orsmoking!

    T"pe of IB9 General Description Indication/

    1rposes

    Date

    Ordered/D

    ate

    Started/Da

    te

    Chan!ed

    Clients

    Response to

    Treatment

    FB 8 ! a g e

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    46/57

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    47/57

    Nursing Prolems0

    (! ,cute pain

    1! ,ctivity

    intolerance

    5! Imalance nutrition0

    Aess than o$yre>uirements

    .ital Signs

    4EMP!

    PR :pm;

    RR:pm;

    /P:mm3g;

    5?!& C22

    1)

    ())'?)

    5?!6 C2=

    (2

    (()'&)

    5&!( C&6

    (?

    (1)'2)

    Diagnostic an$ Aaoratory

    Proce$ure

    3ematology

    /loo$ chemistry

    Me$ical Management0(!I.*

    1! Drugs

    9mepra#ole

    Meperi$ine

    3y$rochlori$e

    Metocloprami$e Ceftriaxone So$ium

    Brso$iol

    Aactulose

    5! Diet

    D=ARs (A

    NP9 except me$ication

    C/R +' /RP

    D=ARs (A

    PNSS (A

    PNSS (A

    NP9

    C/R +' /RP

    PNSS (A

    Soft Diet

    May sit up on e$

    1TI:NT ND 3IS CR:6 DI:T

    FC 8 ! a g e

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    48/57

    T"pe of:?ercise

    GeneralDescription

    Indication /1rposes

    Clients Response and/orReaction to the Diet

    Complete0ed Rest >ith0athroom1rivile!es

    5a" sit p on

    bed

    !atient should beon bed most of thetime to decreaseo"ygen demandand to lessen thefeeling of pain buthe can go to thebathroom whenneeded.

    ' type of e"ercisewherein the patientis being0epositioned every7-> hours.

    This was orderedto conserveenergy, promoterecovery andprovide rest toprevent fatigueand feeling ofpain. It is alsoordered todecrease o"ygendemand.

    To improvecirculation, toprevent venousstasis,thrombophlebitis,respiratorycomplications ands$in brea$down.

    The patient was $ept in bed mostof the time and was able toconserve energy through bedrest as evidenced by patientMsverbalization of decreasedfatigue and wea$ness.

    !atient did not manifest pain in

    the calf upon dorsi(e"ion on thefoot and maintained s$inintegrity.

    1TI:NT ND 3IS CR:6 CTIBIT4

    T"pe of Diet GeneralDescription

    Indication /1rposes

    DateOrdered

    Clients

    Responseand/or

    Reaction tothe Diet

    FN 8 ! a g e

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    49/57

    N1O $Nothin!1er Orem)

    Soft Diet

    !@ orders are nothingper orem diets whichmeans that the patientis not allowed any typeof food or drin$.

    This is to introduce adiet that is easy todigest and allow the ;Itract to be ad#ustedwith limitation of foodsrich in fats.

    To assess theclientMs labresultswithout anyvariance of

    aAected food.

    6oft diet wasordered toallow the ;Itract toreceive foodsthat are easyto digest soas to preventgastricirritation andto promoteeasierdigestion

    ovember7L, >=7E

    ovember>7, >=7E

    'dministration ofI5 preventedthe patient fromdehydration. Thepatient

    cooperated wellwith theprescribed diet.

    ;I discomfortli$e abdominalpain waslessenedbecause of thedecreasedcontraction ofthe gallbladder

    CI:NTS DRUG T3:R134

    Name

    Dosa!e,

    Rote

    and

    9re@enc

    "

    General ctionIndication /

    1rpose

    Date ordered,

    Date

    performed,

    chan!ed or

    D/C

    C

    Res

    me

    >it

    side

    0rand Name6!rilosec,

    0apine",

    Wegerid, &osec.

    Generic

    Name6

    @meprazole.

    Dosa!eMF=mg

    Rote

    M

    Intravenou

    s

    MThought to be agastric pump

    inhibitor in that it

    bloc$s the nal

    step of acid

    production by

    inhibiting the

    /SQHS 'T!ase

    M6hort % termtreatment of active

    duodenal ulcer.

    Xwith clarithomycin

    to treat duodenal

    ulcer associated

    with H.pylori.

    Date Ordered6ovember 7L,

    >=7E

    Date

    1erformed6

    ovember 7L,

    >=7E

    CNS/ead

    Dizzi

    GI6 '

    !ain,

    3em

    FL 8 ! a g e

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    50/57

    Classication6

    !roton !ump

    Inhibitor

    9re@enc

    "

    M@nce a

    day

    system at the

    secretory surface

    of the gastric

    parietal cell. oth

    basal and

    stimulated acid

    secretions are

    inhibited.

    X6hort-term

    treatment of active

    benign gastric

    ulcer.

    X&ong-term

    treatment of

    hypersecretory

    conditions.

    X0educe ris$ of

    upper ;I leeding

    in critically ill

    clients.

    Date Chan!ed6

    Q'

    Discontine6

    Q'

    6

    /em

    'nem

    5isc

    !ain,

    mala

    Name

    Dosa!e,

    Rote

    and

    9re@enc

    "

    General ctionIndication /

    1rpose

    Date ordered,

    Date

    performed,

    chan!ed or

    D/C

    C

    Res

    me

    >it

    side0rand Name6

    Demerol

    Dosa!e

    M>Bmg

    X@ne-tenth as

    potent an

    analgesic as

    X'nalgesic for

    moderate to severe

    pain.

    Date Ordered6

    ovember 7L,

    >=7E

    N

    e2e

    B= 8 ! a g e

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    51/57

    Generic

    Name6

    4eperidine

    /ydrochloride

    Classication6

    arcotic

    'nalgesic

    Rote

    M

    Intravenou

    s

    9re@enc

    "

    M's

    needed

    morphine. Its

    analgesic eAect is

    only one-half when

    given !@ rather

    than parenterally.

    /as no antitussive

    eAects and does

    not produce

    miosis. &ess

    smooth muscle

    spasm,

    constipation, and

    antitussive eAect

    than than

    equianalagesic

    doses of morphine.

    Date

    1erformed6

    ovember 7L,

    >=7E

    Date Chan!ed6

    Q'

    Discontine6

    Q'

    ma

    b" t

    Name

    Dosa!e,

    Rote

    and

    9re@enc

    "

    General ctionIndication /

    1rpose

    Date ordered,

    Date

    performed,

    chan!ed or

    D/C

    C

    Res

    me

    >it

    sid

    B7 8 ! a g e

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    52/57

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    53/57

    " D/C>it

    sid0rand Name6

    0ocephin

    Generic

    Name6

    eftria"one

    6odium

    Classication6

    ephalosporin

    Dosa!e

    M7g

    Rote

    MIntraven

    ous

    9re@enc

    "

    MqN

    X Oor$s by

    inhibiting the

    mucopeptide

    synthesis in the

    bacterial cell wall.

    The beta-lactam

    moiety of eftri"one

    binds to

    cabo"ypeptidases,

    endopeptidases, and

    transpeptidases in

    the bacterial

    cytoplasmic

    membrane. These

    enzymes are

    involved in cell-wallsynthesis and cell

    division. y binding

    to these enzymes,

    eftria"one results

    in the formation of

    defective cell walls

    and cell death.

    XIntra-abdominal

    infections due to

    K.coli, H.

    penumoniae, .

    fragilis, lostridium

    species most

    strain of . di+cle

    are resistantJ and

    !eptostreptococcus

    species.

    Date Ordered6

    ovember 7L,

    >=7E

    Date

    1erformed6

    ovember 7L,

    >=7E

    Date

    Chan!ed6

    Q'

    Discontine6

    Q'

    No

    e2e

    man

    b" t

    BE 8 ! a g e

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    54/57

    Name

    Dosa!e,

    Rote

    and

    9re@en

    c"

    General ctionIndication /

    1rpose

    Date ordered,

    Date

    performed,

    chan!ed or

    D/C

    Cl

    Resp

    med

    >ith

    side0rand Name6

    1sosan

    Generic

    Name6

    1rsodiol

    Classication6

    ;allstone

    solubilizing

    drug

    Dosa!e

    M>==mg

    7

    capsuleJ

    Rote

    M@ral

    9re@en

    c"

    Mid

    Xaturally occurring

    bile acid that inhibits

    the hepatic

    synthesis and

    secretion of

    cholesterol: it also

    inhibits intestinal

    absorption of

    cholesterol. 'cts to

    solubilize cholesterol

    in micelles and to

    cause dispersion ofcholesterol as liquid

    crystals in aqueous

    media. 'bout L=? is

    absorbed in the

    small intestine after

    !@ administration.

    1ndergoes a

    signicant rst-pass

    eAect where it is

    con#ugated with

    either glycine or

    taurine and then

    secreted into hepatic

    bile ducts.

    XDissolution of

    gallstones in clients

    with radiolucent,

    non-calcied

    gallstones in whom

    elective surgery

    would be ris$y or in

    those who refuse

    surgery.

    Date Ordered6

    ovember 7L,

    >=7E

    Date

    1erformed6

    ovember 7L,

    >=7E

    Date Chan!ed6

    Q'

    Discontine6

    Q'

    GI6

    aus

    vom

    abdo

    pain

    chole

    CNS

    /ead

    fatig

    BF 8 ! a g e

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    55/57

    Name

    Dosa!e,

    Rote

    and

    9re@en

    c"

    General ctionIndication /

    1rpose

    Date ordered,

    Date

    performed,

    chan!ed or

    D/C

    C

    Res

    me

    >it

    side0rand Name6

    ephulac,

    hronulac,

    onstilac,

    onstulose

    Generic

    Name6

    &actulose

    Classication6

    ephalosporin

    Dosa!e

    ME= cc

    Rote

    M@ral

    9re@en

    c"

    Monce a

    day at

    bed

    time.

    XIn the colon,

    &actulose is bro$en

    down primarily to

    lactic acid.

    4etabolized in the

    colon by bacteria.

    XTreatment of

    constipation:

    prevention and

    treatment of portal-

    systemic

    encephalopathy,

    including stages of

    hepatic precoma

    and coma.

    Date Ordered6

    ovember 7L,

    >=7E

    Date

    1erformed6

    ovember 7L,

    >=7E

    Date Chan!ed6

    Q'

    Discontine6

    Q'

    GI6 '

    disco

    and

    aus

    5om

    BB 8 ! a g e

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    56/57

    BII% CONCUSION

    @ur gallbladder is one of the important organs in our body. /owever, ma#ority of

    us tend to forget its function and importance. holecystitis or the in(ammation of

    the gallbladder because of an obstruction is a disease that requires a medical

    attention. It adds on the morbidity and mortality rate of gall stone diseases. Thus, it

    is one of the common diseases in our country since one contrubuting factor is the

    food that we eat. This obstruction needs immediate attention because it may cause

    many complications. The harm that gallstones could give is that they may leave the

    gallbladder and enter the small intestine which causes the patient to e"perience

    abdominal pain.

    Through this study, everyone will become aware of hisQher health and daily

    lifestyles. Therefore, we conclude that in order to lower the ris$ of having this $indof condition, each and every one of us must be conscious on our diet especially

    when it comes to our food preferences. Though there is a saying that, )4as

    masarap pag bawal*, we should still be cautious of the foods served in our dining

    table % especially if itMs high in sodium and fat. 's Dr. /arry Vohnson stated that the

    secret to good health lies in every decision that human beings ma$e.

    B 8 ! a g e

  • 8/9/2019 CHOLECYSTITIS CASE STUDY Version 2.0.docx

    57/57

    BIII% R:CO55:NDTIONS

    To the !hilippine ;overnment, they may be aware of increasing incident of thedisease condition in our country and that they may help those who are less

    fortunate by ma$ing the health care services more aAordable and acceptable:

    or the students who will study holecystitis as their case, that they may $now

    the diAerent causes of the said condition and understand the pathology of the

    disease and how the signs and symptoms manifest. That they may also $eep in

    mind the importance of the patientMs information which could be obtained on the

    chart.

    or student nurses who will be handling patients with this condition, health

    education must always be done during nurse-patient interaction. Teaching patients

    proper ways in maintaining healthy lifestyle and importance of proper nutrition.

    or patients with ris$ factors in developing any of the conditions that lead to

    biliary obstruction, awareness of the signs and symptoms can improve chances for

    early diagnosis and improved outcome.